Article Information
- Received October 1, 2021
- Revision received February 2, 2022
- Accepted February 9, 2022
- First published March 10, 2022.
Author Information
- Thilini P. Wijesekera,
- Zheng Wu,
- Nicole P. Stephens,
- Rahul Godula,
- Linda Kao Lew, and
- Nigel S. Atkinson
- Department of Neuroscience and The Waggoner Center for Alcohol and Addiction Research, The University of Texas at Austin, Austin, TX 78712
- Corresponding Author:
Nigel S. Atkinson,Email:
nigela{at}utexas.edu
Author contributions
T.W. and N.A. designed research; T.W., Z.W., N.S., R.G., and L.L. performed research; T.W., Z.W., N.S., R.G., and N.A. analyzed data; T.W. and N.A. wrote the first draft of the paper; T.W. and N.A. edited the paper; N.A. contributed unpublished reagents/analytic tools; N.A. wrote the paper.
Disclosures
The authors declare no competing interests financial or conflicting.
This work was supported by National Institute on Alcohol Abuse and Alcoholism Grant 2R01AA018037-06A1 to NSA. We thank Jane Kirschman for copyediting and other feedback on the manuscript, Adron Harris (University of Texas at Austin) for comments on the manuscript, Steven Wasserman (University of California San Diego) for DifA, DifB, and J4 lines and the anti-DifB antibody and Dominique Ferrandon (Institut de Biologie Moléculaire et Cellulaire Stasbourge France) for the anti-DifA antibody.
Funding
HHS | NIH | National Institute on Alcohol Abuse and Alcoholism (NIAAA)
2R01AA018037-06A1
Other Version
- You are currently viewing a previous version of this article (March 10, 2022).
- View the most recent version of this article
Jump to comment: